In Vitro Studies with Cefaclor, a New Oral Cephalosporin

Abstract

In vitro studies were performed to evaluate the activity of cefaclor in comparison with cephalexin against 180 clinical isolates. Broth dilution susceptibility tests showed cefaclor to be 4- to 16-fold more active than cephalexin against Streptococcus pneumoniae, Haemophilus influenzae , and cephalothin-susceptible Enterobacteriaceae . Neither drug was highly active against cephalothin-resistant Enterobacteriaceae or methicillin-resistant Staphylococcus aureus . Cefaclor zones with 30-μg disks were generally larger than cephalexin zones, 4 mm larger than cephalothin zones against Enterobacteriaceae , and 6 mm smaller than cephalothin zones against S. aureus . Quantitative kill curves indicated that killing by both cefaclor and cephalexin was slow and often incomplete over a 24-h period. Cefaclor-induced filamentation of gram-negative bacilli was not as extensive as that produced by cephalexin, and some spherule formation did occur. However, cefaclor was significantly more unstable in solution than cephalexin, with a half-life of less than 6 h at 37°C. Thus, results obtained in tests after prolonged incubation may not provide an accurate measure of cefaclor's activity.